INVALID CRM

0 shares at $187.27 on 2026-05-05

Reasoning

[REJECTED: no price available] CRM thesis #238 intact. Stock at $187.28 trading at ~20x P/E vs. software average 30x—significant value gap. May 27 earnings (3 weeks out) is next binary event. Barclays identified as leading infrastructure software play; Google Cloud partnership expanding Agentforce integration provides fundamental support. Post-today's buy, position is ~0.82 shares. Adding $150 (modest sizing) ahead of earnings is justified but position kept intentionally small given binary risk. Corroborating macro and news signals present (Rule #39 satisfied).

Thesis

Salesforce is under pressure from multiple vectors: stock down ~30% YTD on AI disruption fears, and today dropped another 3.7% to $180 — below our cost basis. The latest trigger was new AI model releases from Anthropic and OpenAI that threaten the SaaS application layer. However, fundamental case remains: Q4 FY26 EPS beat by 25%, Agentforce ARR growing (2.4B agentic work units, +57% QoQ), $25B buyback supporting price, and 35 analysts have consensus Buy with $279 average PT (49% upside from current). May 27 Q1 FY27 earnings is the key binary event. The AI disruption narrative may be overdone for near-term — Salesforce's data moat, compliance features, and hybrid pricing model provide resilience. But the stock is fighting sentiment headwinds until earnings prove the model works. (long, medium confidence)

Cited evidence

News

Macro